Condition
Malignant Mesothelioma
Estimated Enrollment: 59
Age Group: up to 69 Years (Child, Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Primary Purpose: Treatment
Study ID Numbers: EORTC-08031|2004-004273-28
Study First Received: September 26, 2005
Last Updated: July 17, 2012
Estimated Primary Completion Date: August 2007
Primary Outcome Measures:
Feasibility in terms of 90-day progression-free survival|Toxicity|Progression-free survival|Overall survival
Sponsors and Collaborators:
European Organisation for Research and Treatment of Cancer – EORTC
Website Link: https://ClinicalTrials.gov/show/NCT00227630
